Cytel, Inc.
1050 Winter St
Suite 2700
Waltham
Massachusetts
02451
United States
Tel: (617) 661-2011
Website: https://careers.cytel.com/go/View-All-Jobs...
Email: recruiting@cytel.com
About Cytel, Inc.
Cytel is the largest provider of statistical software and advanced analytics for clinical trial design and execution. For over thirty years, Cytel’s scientific rigor and operational excellence have helped biotech and pharmaceutical companies navigate uncertainty, prove value and unlock the full potential of their data.
Our expansive FSP team and project-based services employ world-class biometrics expertise to accelerate high-quality deliverables. Our software team continues to produce a package of products that enable these methods to diffuse across the industry, driving up the probability of success. These include East, Compass, StatXact, LogXact, ACES (for DMC Services), Enforesys for patient recruitment, and from 2020 Solara – a software platform that synthesizes statistics and strategy to help you achieve your development goals.
A scientific community of passionate and curious individuals, we channel our enthusiasm towards developing evidence-driven results for our clients.
46 articles about Cytel, Inc.
-
Nordic Capital and Astorg Invest in Pharmaceutical Technology and Advanced Analytics Company Cytel
12/21/2020
Nordic Capital and Astorg Invest in Pharmaceutical Technology and Advanced Analytics Company Cytel Cytel is one of the leading global providers of clinical trial design technology, biometric services and advanced analytics, focusing on optimizing clinical trials and helping pharmaceutical companies to unlock the full potential of their clinical and real-world data
-
Global COVID-19 Clinical Trial Tracker launched by Cytel
4/8/2020
Cytel Inc. has launched an open-access global COVID-19 Clinical Trial Tracker to help facilitate greater collaboration between researchers, policymakers, clinicians, journalists, philanthropists, and other critical stakeholders who need to understand the complex dynamics of the global response to finding a solution to the COVID-19 outbreak.
-
Cytel champions precision oncology master protocol trial designs
3/4/2020
new paper authored by statistical experts at Cytel has been published in the world-renowned journal CA: A Cancer Journal for Clinicians.
-
Cytel to hold Complex Innovative Trial Design Symposium
10/17/2019
Cytel Inc. has announced that the Complex Innovative Trial Design Symposium and East® Training will take place November 6–7 at Alexion’s headquarters in Boston, Massachusetts.
-
Cytel launches East On Demand bringing adaptive clinical trial design capabilities to wider biopharma audience
7/25/2019
Cytel Inc., the leading global provider of analytical solutions to the life sciences industry, today announced that it will launch East On Demand™ at the annual Joint Statistical Meetings (JSM) 2019 (July 27 – August 1, Denver, Colorado)
-
Cytel and Axio join forces to create an industry leader in analytical solutions for drug development
6/4/2019
Cytel Inc., the leading global provider of innovative analytical software and services to the life sciences industry, and Axio Research, a premier provider of biostatistics to pharmaceutical, biotechnology and medical device companies, today announced that they have joined forces to create the largest global biometrics organization focused on delivering advanced analytical solutions for the life sciences industry.
-
Cytel Hosts Careers Open Evening at King of Prussia Site
8/16/2018
Cytel Inc. announces a careers open evening and networking event at its King of Prussia, Pennsylvania site.
-
Pharma and biotech companies across the globe continued to expand and reshape their leadership teams with new hires this past week. BioSpace collected several announced leadership appointments, which includes new chief executive officers, new members to boards of directors and more.
-
Cytel Announces Partnership With New Mountain Capital
11/1/2017
Cytel announced that it has partnered with New Mountain Capital, a growth-oriented investment firm that currently manages over $20 billion in assets.
-
Cytel Adds New Basel Location In Continued Expansion
10/6/2017
-
Cytel to Hire 100+ Biostatisticians, Statistical Programmers and Data Managers in Expansion
9/13/2017
-
Cytel Collaboration Wins Most Innovative Clinical Trial Design At The CARE Awards 2017
4/13/2017
-
Cytel Announces Integrated Quantitative Pharmacology And Pharmacometrics Team At ASCPT
3/13/2017
-
Cytel And AstraZeneca PLC Early Clinical Development Software Collaboration Facilitates Clinical Development Decision-Making
11/29/2016
-
Cytel Expands European Footprint And Extends Big Data Capabilities
10/25/2016
-
Cytel Highlights Biostatistics And Programming Expansion At PhUSE 2016
10/7/2016
-
Cytel President Explains Benefits of Adaptive Trial Design
8/9/2016
-
Cytel Publication In The New England Journal of Medicine Propels Adaptive Design Into The Mainstream Of Medical Research
7/7/2016
-
Cytel Highlights Its Quality Biometrics Outsourcing Services At DIA In Wake Of Continued Expansion
6/21/2016
-
Cytel Breaks New Ground In Adaptive Designs With East 6.4 Release
5/24/2016